Abstract
Virus, a sub-microscopic infectious agent that replicates only inside the living cells of a host, causes viral infection. Currently, the immediate imperative is to control the combat against novel coronavirus outbreak caused by the COVID-19 virus, which started in China and spread all over the world. The domain of travelling has emphasized COVID-19 virus prevention as a serious issue for the safety of human beings. The exponential rise in the number of corona patients is a matter of concern for governing bodies of various countries in spite of countless cooperative efforts put in by citizens, organizations and government. India is now among the top worst hit nation in terms of the spread of COVID-19 pandemic. The present article reviews various state-of-art medicinal approaches available that are presently used to control the spread of coronavirus pandemic.
Keywords: Virus, infection, COVID-19, drug candidates, SARS-CoV-2, MERS.
Graphical Abstract
Mini-Reviews in Medicinal Chemistry
Title:Coronavirus (COVID - 19): Chemical Entities of Biological Interest
Volume: 21 Issue: 17
Author(s): Aman Mahajan and Princy Gupta*
Affiliation:
- Assistant Professor, Department of Chemistry and Chemical Sciences, Central University of Jammu, Rahya-Suchani (Bagla), District-Samba, Jammu-181143, J&K,India
Keywords: Virus, infection, COVID-19, drug candidates, SARS-CoV-2, MERS.
Abstract: Virus, a sub-microscopic infectious agent that replicates only inside the living cells of a host, causes viral infection. Currently, the immediate imperative is to control the combat against novel coronavirus outbreak caused by the COVID-19 virus, which started in China and spread all over the world. The domain of travelling has emphasized COVID-19 virus prevention as a serious issue for the safety of human beings. The exponential rise in the number of corona patients is a matter of concern for governing bodies of various countries in spite of countless cooperative efforts put in by citizens, organizations and government. India is now among the top worst hit nation in terms of the spread of COVID-19 pandemic. The present article reviews various state-of-art medicinal approaches available that are presently used to control the spread of coronavirus pandemic.
Export Options
About this article
Cite this article as:
Mahajan Aman and Gupta Princy *, Coronavirus (COVID - 19): Chemical Entities of Biological Interest, Mini-Reviews in Medicinal Chemistry 2021; 21 (17) . https://dx.doi.org/10.2174/1389557521666210125145700
DOI https://dx.doi.org/10.2174/1389557521666210125145700 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
COVID-19 Infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment
Current Pharmaceutical Design Prevention, Diagnosis and Treatment of COVID-19: A Nanotechnological Perspective
Current Nanoscience Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents
Current Drug Targets Predicting the Activity of ACE Inhibitory Peptides with a Novel Mode of Pseudo Amino Acid Composition
Protein & Peptide Letters COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development
Pharmaceutical Nanotechnology Postpartum Posterior Reversible Encephalopathy Syndrome in a Patient Suspected to COVID-19
Anti-Infective Agents An Overview of Novel Coronavirus Disease 2019: A Global Havoc
Coronaviruses SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Current Medicinal Chemistry COVID-19: Are Experimental Drugs a Cure or Cause?
Current Drug Safety Impact of Metaheuristic Techniques in Pandemic of COVID-19
Coronaviruses Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations
Current Pharmaceutical Design A Mini Review: Origin, Treatments, Preventions, Real Facts and Viability of the Recent Pandemic of Novel Coronavirus-2019
Coronaviruses Management of Idiopathic Intracranial Hypertension During the COVID-19 Pandemic
Reviews on Recent Clinical Trials A Brief Outlook on Possible Available Solutions, Therapies and Suggestions for COVID-19
Coronaviruses A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review
Coronaviruses Vaccine Development Against SARS-CoV-2: From Virology to Vaccine Clinical Trials
Coronaviruses Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread
Coronaviruses Patent Selections
Recent Patents on Anti-Infective Drug Discovery Review on the Clinical Pharmacology of Hydroxychloroquine Sulfate for the Treatment of COVID-19
Current Drug Metabolism <i>In Silico</i> Prediction and Designing of Potential siRNAs to be used as Antivirals Against SARS-CoV-2
Current Pharmaceutical Design